摘要
地中海贫血是临床常见的遗传性慢性溶血性疾病,以珠蛋白肽链生成障碍为主要特征,目前该病的分子基础及遗传方式已较为明确,其诊疗方式及病理机制研究均取得了较大进展。本文现对地中海贫血的诊疗现状及分子生物学研究进行阐述。
Thalassemia is a common clinical hereditary hemolytic anemia disease,which is characterized by the disorder of globin peptide chain formation.At present,the molecular basis and genetic mode of the disease have been relatively clear,and great progress has been made in the research on its diagnosis,treatment and pathological mechanism.In this paper,the diagnosis and treatment status of thalassemia and molecular biology research are reviewed.
作者
吕丽娜
杨灿华
LYU Li-na;YANG Can-hua(Department of Hematology,Wuming Hospital Affiliated to Guangxi Medical University,Nanning 530199,Guangxi,China)
出处
《医学信息》
2022年第11期33-36,共4页
Journal of Medical Information
